Literature DB >> 2822992

Participation of the myeloperoxidase-H2O2-halide system in immune complex nephritis.

R J Johnson1, S J Klebanoff, R F Ochi, S Adler, P Baker, L Sparks, W G Couser.   

Abstract

Neutrophils (PMNs) mediate injury in experimental glomerulonephritis (GN) in part via the release of reactive oxygen species, particularly hydrogen peroxide (H2O2). Recent kidney perfusion studies demonstrate that H2O2 can cause glomerular injury by reaction with halides in the presence of the PMN cationic enzyme myeloperoxidase (MPO) to form oxidants which can oxidize and halogenate tissue. We sought evidence for participation of the MPO system in a model of PMN-mediated immune complex (IC) GN. A PMN-dependent model of GN was developed in rats by perfusing the renal artery with concanavalin A followed by anticoncanavalin A antibody. PMN depletion abolished glomerular PMN infiltration and significantly reduced proteinuria (35 +/- 7 mg/day vs. 113 +/- 10, P less than 0.001). Rats that received Na125I (5.0 microCi) three and six hours following disease induction had more 125I incorporation in glomeruli and GBM at 48 hours than similarly treated rats that were PMN depleted (1200 cpm vs. 88 cpm, P less than 0.01). Glomerular iodination could not be demonstrated in a PMN-independent model of nephrotoxic nephritis induced with noncomplement fixing anti-GBM antibody. These data indicate that this model of PMN-mediated IC GN is associated with activation of the MPO-H2O2-halide system, which may participate in mediating glomerular injury.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 2822992     DOI: 10.1038/ki.1987.215

Source DB:  PubMed          Journal:  Kidney Int        ISSN: 0085-2538            Impact factor:   10.612


  18 in total

1.  Structural characterization of the mesangial cell type IV collagenase and enhanced expression in a model of immune complex-mediated glomerulonephritis.

Authors:  D H Lovett; R J Johnson; H P Marti; J Martin; M Davies; W G Couser
Journal:  Am J Pathol       Date:  1992-07       Impact factor: 4.307

2.  Inhibition of human lymphocyte function by organic solvents.

Authors:  A S Shoker; M A Murabit; F F Georges; L F Qualtiere; H G Deneer; K Prasad
Journal:  Mol Cell Biochem       Date:  1997-06       Impact factor: 3.396

Review 3.  Leukocytes in glomerular injury.

Authors:  Stephen R Holdsworth; Peter G Tipping
Journal:  Semin Immunopathol       Date:  2007-10-16       Impact factor: 9.623

4.  Mechanisms of clearance of immune complexes from peritubular capillaries in the rat.

Authors:  C E Alpers; K L Hudkins; P Pritzl; R J Johnson
Journal:  Am J Pathol       Date:  1991-10       Impact factor: 4.307

5.  Immunological evidence for hypochlorite-modified proteins in human kidney.

Authors:  E Malle; C Woenckhaus; G Waeg; H Esterbauer; E F Gröne; H J Gröne
Journal:  Am J Pathol       Date:  1997-02       Impact factor: 4.307

6.  An evaluation of the neutrophil as a mediator of in vivo renal ischemic-reperfusion injury.

Authors:  M A Thornton; R Winn; C E Alpers; R A Zager
Journal:  Am J Pathol       Date:  1989-09       Impact factor: 4.307

7.  Intraglomerular basement membrane translocation of immune complex (IC) in the development of passive in situ IC nephritis of rats.

Authors:  Y Fujigaki; M Nagase; N Honda
Journal:  Am J Pathol       Date:  1993-03       Impact factor: 4.307

Review 8.  New insights into mechanisms of immune glomerular injury.

Authors:  W G Couser
Journal:  West J Med       Date:  1994-05

9.  Proteinuria in passive Heymann nephritis is associated with lipid peroxidation and formation of adducts on type IV collagen.

Authors:  T J Neale; P P Ojha; M Exner; H Poczewski; B Rüger; J L Witztum; P Davis; D Kerjaschki
Journal:  J Clin Invest       Date:  1994-10       Impact factor: 14.808

10.  Acute experimental glomerulonephritis induced by the glomerular deposition of circulating polymeric IgA-concanavalin A complexes.

Authors:  J C Davin; C Dechenne; J Lombet; B Rentier; J B Foidart; P R Mahieu
Journal:  Virchows Arch A Pathol Anat Histopathol       Date:  1989
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.